Literature DB >> 20624390

p38 MAPK pathway is involved in high glucose-induced thioredoxin interacting protein induction in mouse mesangial cells.

Yunzhuo Ren1, Yonghong Shi, Yuehua Wang, Yingmin Li, Shuhui Wu, Hang Li, Yanling Zhang, Huijun Duan.   

Abstract

Excessive reactive oxygen species (ROS) play a key role in the pathogenesis of diabetic nephropathy. The thioredoxin (TRX) system, a major thiol antioxidant system, regulates the reduction of intracellular ROS. Here we show that high glucose (HG) inhibits TRX ROS-scavenging function through p38 mitogen-activated protein kinase (MAPK)-mediated induction of thioredoxin interacting protein (TXNIP) in mouse mesangial cells (MMCs). Knockdown of TXNIP in MMCs reversed HG-induced reduction of TRX activity and inhibited HG-induced activation of p38 MAPK and increased synthesis of TGF-beta1 and fibronectin. These data suggest that HG-induced overexpression of TXNIP in MMCs, which may be via the p38 MAPK pathway. Copyright (c) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624390     DOI: 10.1016/j.febslet.2010.07.010

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Involvement of thioredoxin-interacting protein (TXNIP) in glucocorticoid-mediated beta cell death.

Authors:  E Reich; A Tamary; R Vogt Sionov; D Melloul
Journal:  Diabetologia       Date:  2012-01-14       Impact factor: 10.122

Review 2.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.

Authors:  Samuel Lee; Soo Min Kim; Richard T Lee
Journal:  Antioxid Redox Signal       Date:  2012-06-26       Impact factor: 8.401

3.  Mitochondria-targeted antioxidant attenuates high glucose-induced P38 MAPK pathway activation in human neuroblastoma cells.

Authors:  Mingfeng Cao; Jinjiao Jiang; Yifeng Du; Peng Yan
Journal:  Mol Med Rep       Date:  2012-01-09       Impact factor: 2.952

4.  Thioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus.

Authors:  Hiroshi Masutani; Eiji Yoshihara; So Masaki; Zhe Chen; Junji Yodoi
Journal:  J Clin Biochem Nutr       Date:  2011-10-26       Impact factor: 3.114

Review 5.  O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?

Authors:  Victor V Lima; Kathryn Spitler; Hyehun Choi; R Clinton Webb; Rita C Tostes
Journal:  Clin Sci (Lond)       Date:  2012-10       Impact factor: 6.124

6.  Anthocyanins inhibit high glucose-induced renal tubular cell apoptosis caused by oxidative stress in db/db mice.

Authors:  Jinying Wei; Haijiang Wu; Haiqiang Zhang; Fang Li; Shurui Chen; Baohua Hou; Yonghong Shi; Lijuan Zhao; Huijun Duan
Journal:  Int J Mol Med       Date:  2018-01-10       Impact factor: 4.101

7.  Both Ser361 phosphorylation and the C-arrestin domain of thioredoxin interacting protein are important for cell cycle blockade at the G1/S checkpoint.

Authors:  Kazuyo Kamitori; Fuminori Yamaguchi; Youyi Dong; Akram Hossain; Ayako Katagi; Chisato Noguchi; Yuko Hirata; Ikuko Tsukamoto; Naoya Hatano; Masaaki Tokuda
Journal:  FEBS Open Bio       Date:  2018-10-01       Impact factor: 2.693

Review 8.  Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases.

Authors:  Haruka Tsubaki; Ikuo Tooyama; Douglas Gordon Walker
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923

9.  The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and p38 MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats.

Authors:  Li Peng; Jie Li; Yixing Xu; Yangtian Wang; Hong Du; Jiaqing Shao; Zhimin Liu
Journal:  Int J Endocrinol       Date:  2016-04-24       Impact factor: 3.257

Review 10.  The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy.

Authors:  Shudong Wang; Lijuan Ding; Honglei Ji; Zheng Xu; Quan Liu; Yang Zheng
Journal:  Int J Mol Sci       Date:  2016-06-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.